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The aim of this study is to determine the behavioural problems of children with 46XY disorders of sex development (DSD) with
genital ambiguity and to identify the risk factors that may inﬂuence behaviour. The 27 participants (aged 6–18 years) consisted
of 21 patients raised as boys and 6 patients raised as girls. Control data were obtained from a representative sibling of each
patient who was matched for age and gender. The study tool used was the Child Behaviour Checklist (CBCL), which is a parent-
administered questionnaire. The analysis of the behavioural scores revealed that the patient group had poorer scores in the total,
externalizing, and internalizing realms. This group also had poorer scores in the anxious-depressed, social, and rule-breaking
realms as compared to the control group. In addition, the XY-F group had higher scores (more pathological) than the XY-M
group, although the diﬀerence in the scores was not statistically signiﬁcant. A comparison of the prevalence of patients with
scores in the clinical range with that of the control group was not statistically signiﬁcant. These ﬁndings support the
current recommendations that psychological counselling should be an integral part of the professional support oﬀered to
patients with DSD.
1. Introduction
Disorders of sex development (DSD) are deﬁned as congen-
ital conditions in which the development of chromosomal,
gonadal, and anatomic sex is atypical [1]. These disorders
are a heterogeneous group of rare conditions. It has been
estimated that the incidence of patients presenting with
ambiguous genitalia at birth is approximately 1 in 4500–
5500 [2, 3]. These individuals are often exposed to numerous
diagnostic procedures, including surgery, hormonal treat-
ments, and long-term follow-up, which, in addition to the
disorder itself, may cause serious distress [4].
Outcome studies on the psychological well-being of indi-
viduals with DSD have tended to focus on the group with
congenital adrenal hyperplasia [5–7]. Among those with
46XY DSD, the largest group studied has partial androgen
insensitivity syndrome (PAIS) [8]. A long-term follow-up
study of adults with PAIS found that there is increased
psychological distress in this group, as determined by
responses to the Brief Symptom Inventory (BSI) [4]. While
it is clear that some individuals with PAIS experience psycho-
logical distress, it is as yet unclear which subpopulation is
most at risk. Outcomes of mental health in girls and women
aﬀected by complete androgen insensitivity syndrome
(CAIS) vary greatly across studies. For example, psychologi-
cal distress, self-harming behaviour, and suicidal tendencies
are prevalent in some samples of women with CAIS recruited
via physicians or support groups [8]. Similar patterns of psy-
chological distress have been identiﬁed from responses to the
BSI, and suicidal ideation has been observed in 46XY women
with 5-alpha reductase deﬁciency and 17-beta hydroxypro-
gesterone deﬁciency [4, 8].
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The management of DSD is complex and has undergone
major shifts in the last decade. The initial approach was to
apply the “optimal gender policy” whereby the primary
thrust of the management was to normalize the physical
appearance in line with the gender of rearing [9]. Thus, early
constructive surgery was advocated. However, after review-
ing reports from patient advocacy groups and clinicians,
there are recommendations to postpone any corrective
surgery until the child is able to give consent (full consent
policy) although not all clinicians agree with this policy
[10, 11]. It is thus imperative to assess psychological out-
comes of these patients to allow for evaluation of manage-
ment policies which can then guide future clinical practice
guidelines [12, 13].
To this end, in this study, we assessed the behavioural
problems of children with 46XY DSD with genital ambi-
guity. Patients were recruited from the two largest tertiary
centres of paediatric endocrinology in Malaysia: University
Kebangsaan Malaysia Medical Centre (UKMMC) and
University Malaya Medical Centre (UMMC).
2. Research Objective
The general objective of this study was to evaluate the behav-
ioural problems of patients with 46XY DSD with genital
ambiguity. We also sought to identify any risk factors that
may inﬂuence behaviour.
3. Methods and Study Design
3.1. Study Outline. The study was carried out from 1
November 2013 to 30 November 2014. The two centres
involved in this study are the major referral centres for
this condition in Malaysia as they are equipped with both
the paediatric endocrinology and surgical expertise to
manage the condition. All patients with 46XY DSD with
genital ambiguity aged 6–18 years (N = 42) who attended
the paediatric endocrine clinic at UKMMC and UMMC
were invited to participate in the study. Of those, patients
with syndromes, learning disabilities, and neurologic disor-
ders (N = 5) were excluded from the study. Patients who
did not attend the follow-up despite reminders were also
excluded (N = 10). The median age of this group was
11.5 (7.8–13.3) years, signiﬁcantly lower than the patient
group. Therefore, a total of 27 patients were included in the
study: male social sex N = 21 and female social sex N = 6.
All the controls came from the families of cases (N = 27,
males = 21, females = 6), and only one sibling from the family
closest to the case’s age was chosen.
The patients were identiﬁed from clinic records. Written
informed consent was obtained from the parents (or legal
guardians) of all the patients during a clinic visit before
participation. After obtaining informed consent, a self-
administered questionnaire was distributed to the parents.
The questionnaire in all cases was completed by the mother.
Approval for the study was granted by the ethical committee
of UKMMC and of UMMC. The study protocol conformed
to the ethical standards in the Helsinki Declaration II.
Background clinical data were obtained from medical
records and included age at diagnosis, karyotype, gender
assigned, clinical and biochemical data at presentation
including degree of virilization, number and nature of surgi-
cal procedures done, and pubertal status. Current informa-
tion about the patients including pubertal development,
complications, medication, and socioeconomic data were
obtained by physical examination and interview at the
respective clinic.
To group the patients, we applied a classiﬁcation sys-
tem based on karyotype and sex of rearing/recent gender
as used previously by the German network of disorders
of sex development (DSD)/intersexuality and as also sug-
gested by the consensus statement of the ESPE/LWSPE
Conference [2, 14] as follows:
(a) Subgroup 1 (XY-F, N = 6): individuals with XY
karyotype and reared as girls/living as women
(b) Subgroup 2 (XY-M, N = 21): individuals with XY
karyotype and reared as boys/living as men.
3.2. Questionnaire. The study tool was the Child Behaviour
Checklist (CBCL). The proxy version of this tool was used,
that is, the parents answered the questionnaire. An English
version and a version translated into Bahasa Malaysia
(BM) (the national language of Malaysia) were used. The
latter has been validated according to international transla-
tion standards with separate backward and forward trans-
lations [15, 16].
The CBCL used in this study consisted of 118 items or
questions. The parents answered the questions based on the
child’s behaviour over a 6 month period. Parents rated their
child’s demonstration of behaviours by scoring 0 for never,
1 for sometimes, and 2 for always. The behavioural problem
scales are derived from various combinations of the items or
questions. The questionnaire provides three summary scales
and eight syndrome scales. The information from the ques-
tionnaires was entered into a CBCL software program, which
calculated the raw scores, T scores, and score percentiles. The
T scores of the CBCL summary and syndrome scales were
used in the analysis. A high T score indicates a higher risk
of psychopathology in a particular behavioural scale. The T
scores of the summary scales that were above 63 (>97th per-
centile of the normative sample) and those of the syndrome
scales that were above 69 (>97th percentile of the normative
sample) were considered to be the clinical range scores.
3.3. Statistical Analysis. Data was analysed using IBM SPSS
version 22. Statistical diﬀerence was assessed by using
the t-test for parametric data and the Mann–Whitney/
Kruskal-Wallis tests for nonparametric data. For categor-
ical data, the X2 test was used. For identiﬁcation of the
risk factors, bivariate analysis (Pearson’s correlation) was
performed. Statistical signiﬁcance was assumed when
P < 0 05. However, for scale scores, this was adjusted
using the Bonferroni-Holm method to account for multiple
comparisons.
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4. Results
4.1. Patient Cohort and Control. There was no signiﬁcant
diﬀerence between the patient and control groups with
regard to age at CBCL administration, gender distribution,
mean family income, and parental marital status (Table 1).
Similarly, there was no diﬀerence between male and female
patients as compared to male and female controls with regard
to demographic characteristics.
Patient characteristics are summarized in Tables 1, 2,
and 3. The median age of the population was 14 years
(12–15). Twenty-one patients were included in the group
XY-M with a median age of 14 years (10–15), and 6
patients were included in the group XY-F with a median
age of 14.5 years (12.8–18). There was no statistical signif-
icance between the ages of the two groups. Eighteen
patients (66.7%) were adolescents (above 12 years old).
The majority of patients had already had some surgical
procedure, with 14 patients having undergone a genital
reconstruction. Eight patients had three or more surgical
procedures. Nine patients had had a gonadectomy, in seven
cases bilateral. Two patients had a gonadoblastoma at the
time of removal of gonads. One patient with ovotesticular
DSD underwent gender change from female to male.
4.2. CBCL Scores. The total, externalizing, and internalizing
scores were signiﬁcantly higher (more pathological) in the
patient group as compared to the control group (Table 4).
Analysis of syndromic scale scores revealed that the patient
group had signiﬁcantly poorer scores in the anxious-
depressed, social, and rule-breaking dimensions (Table 5).
The XY-F group had higher scores (more pathological) than
the XY-M groups, although the diﬀerence was not statisti-
cally signiﬁcant (Table 6). However, the numbers in each
group were small, thereby limiting the statistical power.
4.3. Prevalence of DSD Patients with Clinical Range Scores. A
chi-square test of independence was performed to examine
the proportion of DSD cases with clinical range scores as
compared to the controls. The analysis revealed that the
diﬀerence between the two groups in terms of prevalence of
clinical range scores was not statistically signiﬁcant (Table 7).
Table 1: Sociodemographic characteristics of cases and control.
Variable Case Control P value
Median age at study
entry in years (IQR)a
14 (3) 13 (3) 0.37
Gender frequency (%)b 0.75
Male 21 (77.8) 20 (74.1)
Female 6 (22.2) 7 (25.9)
Mean family income
RM (SD)c
3851 (1343) 4000 (1487) 0.70
Parental marital statusd
Married 26 26 1.00
Single 1 1
aMann–Whitney; bchi-squared test; cindependent t-test; dFisher’s exact test.
Table 2: Baseline characteristics of DSD cases.
Male (N = 21) Female (N = 6)
Age in years at study entrya 12.6 (3.6) 15 (2.7)
Prader scoreb
2 2 (28)
3 2 (9) 4 (72)
4 13 (65)
5 6 (26)
Surgical proceduresb 16 (76.2) 5 (83.3)
Number of surgical procedures
≤2 8 4
>2 8 1
Gonadectomy 5 4
aMean (standard deviation); bfrequency (%).
Table 3: Chart showing the grouping of patients and the
distribution of diagnosis.
Group
Total
XY-M XY-F
Diagnosis
Gonadal dysgenesis 13 0 13
Mixed gonadal dysgenesis 3 1 4
Androgen insensitivity 1 5 6
Ovotestis 3 0 3
5-alpha reductase deﬁciency 1 0 1
Total 21 6 27
Table 4: Total, internalizing, and externalizing T scores from the
CBCL in patients with XY DSD as compared to the control group.
Case Control P value
Internalizing score∗ 52 (19) 39 (17) 0.002
Externalizing score∗ 51 (17) 40 (16) 0.020
Total∗ 50 (27) 36 (16) 0.025
∗ denotes signiﬁcant variables. Scores are given as median (IQR) with
higher scores denoting poorer outcome.
Table 5: Syndrome scale T scores in patients with XY DSD as
compared to the control group.
Case Control P value
Anxious-depressed∗ 53 (8) 50 (1) 0.004
Withdrawn-depressed 53 (13) 50 (0) 0.007
Somatic problems 50 (8) 50 (3) 0.287
Social∗ 55 (13) 50 (3) 0.002
Thought 50 (5) 50 (0) 0.009
Attention 53 (10) 50 (1) 0.039
Rule-breaking∗ 53 (10) 50 (1) 0.005
Aggressive 51 (7) 50 (1) 0.096
∗ denotes signiﬁcant variables. Scores are given as median (IQR) with
higher scores denoting poorer outcome. P value was adjusted using the
Bonferroni-Holm method to account for multiple comparisons.
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4.4. Associations. A Spearman’s rank-order correlation was
run to determine the relationship between family income
and the CBCL scores. The results showed that there was no
signiﬁcant correlation between family income and the total,
internal, and external CBCL scores. There was also no signif-
icant correlation between degree of virilization (Prader score)
at diagnosis and the total CBCL scores for the population
XY-F (r = − 0 62, P = 0 19) and XY-M (r = 0 12, P = 0 61).
In addition, an evaluation of the eﬀect of repeated surger-
ies on the total, internal, and external CBCL scores did not
reveal a signiﬁcant association. To determine the eﬀect of
the mode of puberty on behavioural outcomes, the total,
internalizing, and externalizing scores of the group who
had experienced spontaneous puberty were compared with
those of the group who had undergone induction of
puberty. There were 4 patients who went into spontaneous
puberty, whereas 17 patients had pubertal induction. The
group of patients who went into spontaneous puberty
had a median age of 14 years (13.3–14), whereas the group
of patients whose puberty was induced had a median age
of 15 years (13–17). There was no signiﬁcant diﬀerence
between the groups.
5. Discussion
In this study, we found that the patient group experienced
increased behavioural problems as compared to the control
group. The analysis of the behavioural scores revealed that
the patient group had signiﬁcantly poorer scores in the total,
externalizing, and internalizing realms. This group also had
signiﬁcantly poorer scores in the anxious-depressed, social,
and rule-breaking realms as compared to the control group.
This ﬁnding is in line with the existing literature. Zhu et al.
[17] demonstrated that in a group of patients with DSD,
psychological problems were signiﬁcantly more prevalent in
the DSD group than in the control group. However, the
prevalence of patients with scores in the clinical range as
compared to the control group did not attain statistical sig-
niﬁcance. It is possible that we did not ﬁnd evidence of severe
emotional problems because of the “sleeper eﬀect,” whereby
patients struggle later in adulthood when the implication of
having DSD becomes more real [18].
Patients with DSD are at greater risk of behavioural prob-
lems and poor psychological outcomes because they encoun-
ter development hurdles that are intense and that are likely to
have negative psychological implications [19]. Repeated
surgery and medical intervention may also have a negative
inﬂuence on the psychological outcome [20]. However, in
this study, we were unable to demonstrate an association
between behavioural outcomes and surgery. The complexity
of the condition may also create psychological distress in
patients. This anxiety may impair cognitive processing and
further impair understanding of the condition. Furthermore,
although the consensus in the ﬁeld is to recommend early
disclosure to patients, in our experience, most parents are
reluctant to divulge the diagnosis to their children. They feel
that this may deprive their children of a happy childhood.
However, there is evidence to the contrary that patients
who are well informed have a greater chance of developing
coping skills and adjusting to the limitations that their diag-
nosis may impose on them [21]. Conversely, in a culture
where a diagnosis of DSD is considered shameful, the added
burden of social isolation and stigmatization may contribute
to increasing psychological distress [22, 23].
We hypothesized that the greatest degree of psychologi-
cal distress would be found in the groups where there was a
discrepancy between the genetic and social sex [24].
Jürgensen et al. [25] in a study of 166 children with DSD aged
4–12 years demonstrated that girls with DSD and androgen
eﬀects show increased cross-gender tendencies. The authors
postulated that this may be either as a direct consequence
of androgen eﬀects or as a more indirect consequence of a
feeling of “being diﬀerent” caused by atypical physical and/
or behavioural characteristics [25]. Thyen et al. [9] in a study
of 110 adults with DSD demonstrated that the XY-F group
reports the lowest scores of satisfaction with the care received
[9]. Our study did demonstrate a trend of poorer scores in the
XY-F group, although it was not statistically signiﬁcant. The
rarity and complexity of this group often leads to a delay in
diagnosis and also to a delay in accessing specialized medical
care. Thus, this may be a group that needs greater
surveillance and psychological support. The authors of a
German clinical evaluation study [25] also recommend that
this group (girls with androgen eﬀects) receive greater atten-
tion as there is a risk of gender insecurity and dysphoria.
However, they also conclude that gender of rearing and
socialization also play a role in gender identity development
[25]. Thus, for this group of patients, parenting and social
relationships are of paramount importance and the patients
and their families should receive appropriate support
throughout the patient’s development phase.
Our study does have some limitations. Firstly, the ques-
tionnaire used was not speciﬁcally designed for the DSD
conditions assessed. However, we do believe that the ques-
tionnaire addressed most of the domains that would be
aﬀected in patients with sex disorders. The results of this
study are also derived from a survey completed by the partic-
ipants’ parents. It is likely that there would be some
Table 7: Percentage of XY DSD patients in clinical range on
syndromic scores as compared to controls.
Case (N) Control (N) P valuea
Internal 22.2% (6) 3.8% (1) 0.10
External 3.7% (1) 7.4% (2) 1.0
Total 13.3% (4) 0% 0.11
aFisher’s exact test.
Table 6: Total, internalizing, and externalizing T scores from the
CBCL in patients with XY-M and XY-F.
XY-M XY-F P value
Internalizing score 52 (16) 52.5 (32) 0.76
Externalizing score 50 (13) 60 (28) 0.24
Total 49 (17) 57.5 (33) 0.32
Scores are given as median (IQR) with higher scores denoting poorer
outcome.
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discrepancy between the results gained from the parents
and from the patients themselves. Therefore, future
research will need to evaluate the patient’s perception as
the primary stakeholder. Also, the control group did not
include individuals with a chronic medical condition.
Presence of a chronic medical condition has been demon-
strated to have an impact on self-esteem, body image, and
risk of depression [26]. We also used the Prader scores to
evaluate the degree of virilization. As the score relates pri-
marily to virilization of the female genitalia in cases of
congenital adrenal hyperplasia, the application of this
score to other conditions may be inaccurate. Due to the
rarity of the disorders, we were also hampered by a small
sample size. This also prevented us from undertaking a
disorder-speciﬁc analysis.
For a comprehensive analysis of the psychological out-
comes of this group of patients, we will also need to take
into account assessment of body image, self-image, and
social relationships. This will be a challenging task given
the reluctance of the current culture in Malaysia to open
up and talk about these issues. Researchers will have to
ﬁnd ways to overcome the subjects’ reticent in divulging
information on these issues [19]. We also acknowledge
that the psychological outcomes of a child with DSD are
heavily inﬂuenced by family dynamics and parenting.
Thus, in the future, we will also need to explore the link
between parental outcomes and the patient’s psychological
outcomes to assess the degree to which the former inﬂu-
ences the latter. This will also aid in the identiﬁcation of
families who are at risk. Studies have also demonstrated
that the DSD patient’s outcome is also inﬂuenced by the
medical practitioner’s attitude and also willingness to
explore psychosocial aspects of disorder management
[27]. We will need to evaluate this in future studies to
determine the extent to which this inﬂuences the patient’s
psychological outcome.
In summary, this study demonstrated that children and
adolescents with DSD have a higher degree of psychological
distress. These ﬁndings support the current recommenda-
tions that psychological counselling should be an integral
part of the professional support oﬀered to patients with
DSD [28–30]. Application of evidence-based psychological
interventions will be able to improve the quality of care
received by these patients. The ﬁndings reported here also
underline the importance of establishing paediatric mental
health services to support the social and behavioural develop-
ment of these patients.
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